More Medical Developments International Limited news
Medical Developments International LimitedASX: MVP

MVP signs major deal with Walgreens in the USA

Feb 12, 2018 at 3:50 AM EST · Issued by Medical Developments International Limited

Filed with ASX · Feb 12, 2018 at 3:50 AM EST · 2 pages · English

On 6ix: 6ix.com/news/mvp-signs-major-deal-with-walgreens-in-the-usa

Watch Medical Developments International's latest callMedical Developments International (ASX:MVP) Q4 2026 Earnings Call · Replay · Aug 19↗

Medical Developments International Limited on 6ix

Earlier from Medical Developments International

  • Penthrox approved in LatviaFeb 9, 2018
  • Penthrox approved in SlovakiaFeb 1, 2018
  • Penthrox approved in AustriaJan 29, 2018
  • Penthrox approved in DenmarkJan 24, 2018
  • Penthrox approved in IcelandJan 22, 2018

Later from Medical Developments International

  • Half Year Report and AccountsFeb 15, 2018
  • First Penthrox order for AustriaFeb 18, 2018
  • Stage II success for new manufacturing technology- LidocaineFeb 20, 2018
  • Global demand for Medical Developments SharesMar 19, 2018
  • Penthrox approved in Sweden, Norway, Poland and CroatiaMar 26, 2018
All Medical Developments International news releases↗

Follow Medical Developments International into a list and get an email when it puts out news.

Follow Medical Developments International
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer